Pantoprazol Noridem (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Noridem, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazol Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Noridem is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Erosive oesophagitis: supports mucosal healing and reduces further erosion. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Adverse reactions to Pantoprazol Noridem vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash. - Fractures (hip, wrist, spine): associated with long‑term use. - Liver enzyme elevation: abnormal liver function tests.

When prescribing Pantoprazol Noridem, consider the following safety measures: - Assess renal function: dose adjustment may be required in severe impairment. - Review hepatic status: use with caution in moderate to severe liver disease. - Evaluate need for long‑term therapy: prolonged use may increase fracture risk. - Monitor electrolytes: especially magnesium during extended treatment. - Consider pregnancy and lactation: weigh benefits against potential risks. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Noridem can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced absorption and efficacy. - Certain antifungal agents (e.g., ketoconazole, itraconazole): markedly decreased bioavailability. - Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Methotrexate: reduced renal clearance may raise toxicity risk. - Digoxin: slight increase in serum levels; observe for signs of toxicity.